Whalesbook
📉 The Financial Deep Dive
The Numbers:
Acutaas Chemicals Limited (formerly Ami Organics Limited) delivered exceptional financial results for Q3 FY26. Revenue from operations grew an impressive 43.0% YoY to ₹3,932 Mn, up from ₹2,750 Mn in Q3 FY25. Profit After Tax (PAT) surged by 133.7% YoY to ₹1,062 Mn, a significant leap from ₹454 Mn in the prior year, achieving the company's highest-ever quarterly PAT. EBITDA followed suit, rising 119.4% YoY to ₹1,507 Mn.
For the nine months ended FY26 (9MFY26), revenue grew 29.8% YoY to ₹9,066 Mn, while PAT saw a substantial 127.3% YoY increase to ₹2,221 Mn.
The Quality:
Profitability metrics demonstrated substantial improvement. EBITDA margins expanded significantly to 38.3% in Q3 FY26, a notable increase from 25.0% in Q3 FY25, attributed to cost improvements and a favorable product mix. PAT margins also widened considerably to 27.0% from 16.5% YoY. Gross Profit saw a 76.1% YoY increase with Gross Margins expanding from 46.2% to 57.0%.
The Grill:
Management has revised its revenue growth guidance for FY26 upwards to approximately 30%, a climb from the earlier projection of 25%. This optimism is supported by a healthy order book and improved business visibility. The company's strategic focus remains on strengthening its core pharmaceutical intermediates business and pursuing CMO/CDMO opportunities. Concurrently, significant investments are being channelled into scaling new verticals: battery chemicals and semiconductor chemicals. Management conveyed confidence that these new businesses are progressing steadily and are slated to become independent growth engines within three years.
🚩 Risks & Outlook
Specific Risks:
While the outlook is positive, potential risks include the execution and market adoption pace for the new battery and semiconductor chemical verticals. Intensifying competition in the specialty chemicals space and global supply chain dynamics could also pose challenges.
The Forward View:
Investors will be keenly watching the ramp-up of the CDMO business and the initial contributions from the battery and semiconductor chemical segments. The company's ability to sustain its high growth trajectory and margin expansion will be key indicators. The strong balance sheet, with reduced borrowings and ongoing CapEx for expansion, provides a solid foundation for future growth.